Skip to content

BIO FRONTIER

  • Home
  • Artificial intelligence
  • Biotechnology
  • Genetics
  • Medical Technology
    • Home
    • Uncategorized
    • Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics MASI among Q4 moves

Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics MASI among Q4 moves

Mar 6, 2026

Post navigation

U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma
Altimmune Reports FY25 Financials: Why Is Big Pharma Staying Away
  • PR Newswire
  • GlobeNewswire
  • Contact
  • Privacy Policy

BIO FRONTIER

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.